For instance, the alkylating agent administered to GBM patients, TMZ, can stimulate the expression of stress-induced antigens such as NKG2D ligands (MICA and ULBPs) on GBM cells (Chitadze et al., 2016). Here, KLRK1 is linked to glioblastoma.